Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT04639375

Active, not recruiting

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

SARS-CoV-2
NCT02673255

Completed

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Healthy
NCT04939155

Active, not recruiting

Methylation Effects of COV-19 Infection and Vaccinations

Covid19
NCT02466750

Unknown

Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine

Western Equine Encephalitis
NCT01673425

Terminated

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Influenza
NCT02459262

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. (MVX13211)

Infection by Streptococcus Group B
NCT03697798

Completed

A Study Exploring Whooping Cough Protection in Children and Adults (BERT)

Pertussis
NCT03615911

Completed

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

MERS (Middle East Respiratory Syndrome)
NCT03685682

Completed

Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients

Varicella Zoster Vaccine
NCT03630627

Completed

A Phase I Study of SB26 in Healthy Volunteers

Healthy Volunteers
NCT04236960

Completed

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Meningococcal Infections
NCT00584454

Completed

Safety Evaluation of a Q-fever Vaccine, NDBR 105

Q Fever
NCT03300843

Terminated

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal Cancer
NCT03458780

Completed

Yellow Fever Immune Response at Single Cell Resolution

Healthy
NCT03341637

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Dengue
NCT03154086

Completed

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

Irritable Bowel Syndrome
NCT02647281

Completed

First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects

Hepatitis B
NCT03089879

Completed

A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Dysentery, Bacillary
NCT02585700

Completed

A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

Influenza, Human
NCT03792022

Unknown

Timeliness and Completeness of Routine Childhood Vaccinations by 2 Years of Age in Nigeria.

Vaccination Failure
NCT01978262

Completed

Immune and Hormone Response to Influenza Vaccine

Healthy
NCT00992784

Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

Influenza
NCT00985790

Completed

Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children

Influenza
NCT00454909

Completed

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Infections, Meningococcal
NCT00871741

Terminated

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Neisseria Meningitidis | Haemophilus Influenzae Type b
NCT00386113

Completed

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly

Influenza
NCT01617629

Completed

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study (CAN-003X)

Epithelial Ovarian Cancer
NCT00349713

Completed

FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali

Malaria | Plasmodium Falciparum Malaria
NCT00001512

Completed

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Lymphoma | Follicular Lymphoma | B Cell Lymphoma
NCT02971670

Completed

Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial

Sepsis | Toxic-Shock Syndrome
NCT02340338

Completed

rTSST-1 Variant Vaccine Phase 1 First-in-man Trail (rTSST-1)

Toxic Shock Syndrome | Vaccination; Sepsis
NCT00587691

Completed

Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis (DES)

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
NCT00316147

Completed

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b
NCT00479648

Completed

A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants

Influenza
NCT02729168

Completed

Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly

Rabies
NCT02266992

Completed

Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study (LAIV)

Acquired Immune Deficiency Syndrome Virus
NCT00956761

Completed

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Seasonal Influenza
NCT01534468

Completed

Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults

Influenza A Subtype H7N7 Infection
NCT01811771

Completed

Oral Cholera Vaccine Delivery in Rural Bangladesh (ROCV)

Cholera
NCT01096134

Completed

Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention (MDI)

Cervical Cancer
NCT01776541

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Pandemic H5N1 Influenza
NCT00595465

Completed

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
NCT00296829

Completed

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection
NCT00992719

Completed

Novartis H1N1 Vaccine in Pregnant Women

Influenza
NCT00004052

Completed

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Leukemia
NCT00920517

Completed

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

Dengue Fever
NCT00881842

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season

Influenza
NCT00873912

Completed

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine (MI-MA205)

Healthy
NCT00677820

Completed

A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine (MI-MA182)

Influenza
NCT00001127

Completed

Study of a Flu Vaccine in Children

Influenza

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations